COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Submits Abstract for First-of-Kind Study Evaluating the Impact of Diarrhea from Cancer Therapies in Breast Cancer Patients Who Received Placebo in its OnTarget Phase 3 Trial
Jaguar Health, Inc. announced a late-breaking abstract on diarrhea management from a placebo group study in breast cancer patients. Further FDA discussions planned -
COMMUNIQUÉ DE PRESSE
NB Private Equity Partners (NBPE): NB: adding value in attractive co-investment sector
Hardman & Co Research highlights how NB Private Equity Partners (NBPE) adds value in the co-investment sector, emphasizing return, cashflow, asset selection, risk management, and GP relationships -
-
COMMUNIQUÉ DE PRESSE
Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version
Mainz Biomed reports increasing demand for enhanced ColoAlert product leading to transition by existing partners to new version, featuring at Medizinische Woche Baden-Baden -
COMMUNIQUÉ DE PRESSE
The global biopharma community is now actively partnering for BIO-Europe® 2024
Global biopharma community actively partnering for BIO-Europe® 2024, leading industry conference in Stockholm, Sweden. Event features workshops, panels, networking opportunities. Celebrating 30 yrs of partnerships & innovation -
COMMUNIQUÉ DE PRESSE
Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises
Bausch Health Companies Inc. and Salix Pharmaceuticals release Liver Health Trends Report highlighting need for improved chronic liver disease care, education, and management -
-
